Safety and Tolerability Trial of Microbial Inulinase

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 28, 2023

Primary Completion Date

October 6, 2023

Study Completion Date

October 6, 2023

Conditions
Digestive HealthGastrointestinal Health
Interventions
DIETARY_SUPPLEMENT

Inulinase

Participants will consume one capsule containing 1,000 INU inulinase, twice daily, for 28 days. Participants will be directed to consume the capsules with their two largest meals.

DIETARY_SUPPLEMENT

Maltodextrin placebo

Participants will consume one capsule containing maltodextrin, twice daily, for 28 days. Participants will be directed to consume the capsules with their two largest meals.

Trial Locations (1)

N1G 0B4

Nutrasource site (Apex Trials), Guelph

All Listed Sponsors
collaborator

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

NETWORK

lead

BIO-CAT, Inc.

INDUSTRY

NCT05744700 - Safety and Tolerability Trial of Microbial Inulinase | Biotech Hunter | Biotech Hunter